Amniotics AB (OSTO:AMNI) Common Stock : kr6.51 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Common Stock?

Amniotics AB's quarterly common stock stayed the same from Jun. 2023 (kr11.28 Mil) to Sep. 2023 (kr11.28 Mil) but then declined from Sep. 2023 (kr11.28 Mil) to Dec. 2023 (kr6.51 Mil).

Amniotics AB's annual common stock stayed the same from Dec. 2021 (kr0.87 Mil) to Dec. 2022 (kr0.87 Mil) but then increased from Dec. 2022 (kr0.87 Mil) to Dec. 2023 (kr6.51 Mil).

Amniotics AB Common Stock Historical Data

The historical data trend for Amniotics AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Common Stock Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

0.19

0.60

0.87

6.51

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial										0.87	0.87	11.28	11.28	6.51

Amniotics AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.